- Imexpharm Pharmaceutical JSC (HOSE: IMP) is the largest antibiotic provider in Vietnam.

- IMP reported record-high results in 2023 with net revenue of VND2tn (+21% YoY) and NPAT-MI of VND300bn (+34% YoY). 

- IMP’s sales from the ETC (essential therapeutic care) channel (channel for prescription drugs, mostly to hospitals) surged 40% YoY due to patient visits to hospitals increasing and higher health insurance coverage in 2023.

Powered by Froala Editor